For on-site conference registration, please click here

For live streaming registration, please click here

Fatty Liver: An Integrated Chinese Medicine Approach to a Growing Global Epidemic

Friday, 10/26 at 2:00 PM to 5:00 PM

1. Learn to identify the patients with liver disease. 2. Learn which lab tests are used to diagnose liver disease and fatty liver. 3. Identify Chinese diagnoses and herbal formulas used for liver support and fatty liver. 4. Understand Western and Eastern management of fatty liver disease. Chances are good that you are treating people with chronic liver disease, including fatty liver, but may not know it. Chronic liver disease affects more 50 million people worldwide yet the vast majority of people with liver disease have not been diagnosed and often feel well until the last stages of disease. The fastest growing chronic liver disease is fatty liver disease and, very soon, will become the primary reason for liver transplant in the developed world. People with liver disease need to be identified, receive a Western diagnostic workup, and use Chinese medicine, nutritional support and other non-pharmaceutical treatments. This course will explore the theory and practice of integrated Chinese medicine for chronic liver disease, especially fatty liver disease in conjunction with metabolic syndrome. Supportive and safe Chinese herbal medicine and acupuncture will be explored. Case studies and open discussion will round out the seminar.

Misha Cohen

Misha Cohen, a Doctor of Oriental Medicine and Licensed Acupuncturist, is the Clinical Director of Chicken Soup Chinese Medicine, Executive Director of the MRCE Foundation, and Research Specialist of Integrative Medicine at the University of California Institute for Health and Aging, all in San Francisco. She is also an elected Fellow to the National Academy of Acupuncture and Oriental Medicine. She has been practicing traditional Asian medicine for the past 38 years.


View the 2018 conference schedule at a glance. The full 2018 program brochure is coming soon.